Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

End of Treatment Peripheral Blood T-Cell Receptor Gene Rearrangement Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

Neha Mehta-Shah, MD, Todd A Fehniger, MDPhD, Eric D Jacobsen, MD, Katrina Peterson, Brad S. Kahl, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Armin Ghobadi, MD, Anne Fischer, BS, Beth Reagan, Alison J. Moskowitz, MD, Fei Wan, Ying Huang, PhD, Kasey Hutt, PhD, Edgar Vigil, Meredith Olson, Austin Jacobsen, Steven M. Horwitz, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-138768

Published: 2020

Journal Articles

A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma

Daniel Guy, MD, Marcus Watkins, PhD, Fei Wan, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Todd A Fehniger, MDPhD, Armin Ghobadi, MD, Neha Mehta-Shah, MD, Brad S. Kahl, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-143095

Published: 2020

Journal Articles

Ontogeny As a Critical Determinant of Natural Killer Cell Potential and Function

Carissa Dege, PhD, Kathleen E. McGrath, PhD, Melissa M Berrien-Elliott, PhD, Katherine H Fegan, MS, Julia Alexandra Wagner, BS, Todd A Fehniger, MDPhD, James Palis, MD, Christopher Sturgeon, PhD

Blood (2018) 132 (Supplement 1): 1271.

https://doi.org/10.1182/blood-2018-99-119812

Published: 2018

Journal Articles

Tocilizumab Is Safe after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Ramzi Abboud, MD BS, Michael Slade, MDMS, Kathryn Trinkaus, PhD, Camille N. Abboud, MD, John F DiPersio, MD PhD, Todd A. Fehniger, MDPhD, Geoffrey L. Uy, MD, Peter Westervelt, MDPhD, Ravi Vij, MDMBA, Mark A. Schroeder, MD, Iskra Pusic, MD, Armin Ghobadi, MD, Rizwan Romee, MD

Blood (2017) 130 (Supplement 1): 3213.

https://doi.org/10.1182/blood.V130.Suppl_1.3213.3213

Published: 2017

Journal Articles

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Cody Ramirez, BS, Kilannin Krysiak, PhD, Felicia Gomez, PhD, Susanna Kiwala, Christopher A. Miller, PhD, Katie Campbell, Jasreet Hundal, Jason Walker, Malachi Griffith, PhD, Obi Griffith, Todd A. Fehniger, MDPhD

Blood (2017) 130 (Supplement 1): 114.

https://doi.org/10.1182/blood.V130.Suppl_1.114.114

Published: 2017

Journal Articles

Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations

Felicia Gomez, PhD, Kilannin Krysiak, PhD, Cody Ramirez, BS, Eric J. Duncavage, MD, Zachary Skidmore, MEng, Grace Triska, BS, Lee Trani, BA, Nancy L. Bartlett, MD, Amanda F. Cashen, MD, Neha Mehta-Shah, MD, Brad S Kahl, MD, Friederike Kreisel, MD, Malachi Griffith, PhD, Todd A. Fehniger, MDPhD, Obi Griffith

Blood (2017) 130 (Supplement 1): 2733.

https://doi.org/10.1182/blood.V130.Suppl_1.2733.2733

Published: 2017

Journal Articles

First-in-Human Clinical Trial of the IL-15 Super-Agonist Complex ALT-803 for Patients Relapsed after Allogeneic Hematopoietic Cell Transplantation

Rizwan Romee, MD, Sarah Cooley, MD, Melissa Berrien-Elliott, PhD, Peter Westervelt, MDPhD, Michael R Verneris, MD, John E. Wagner, MD, Daniel J. Weisdorf, MD, Bruce Blazar, MD, John F DiPersio, MD PhD, Amanda F. Cashen, MD, Emily K Jeng, Amy Rock, Hing C Wong, PhD, Todd A. Fehniger, MDPhD, Jeffrey S. Miller, MD

Blood (2017) 130 (Supplement 1): 274.

https://doi.org/10.1182/blood.V130.Suppl_1.274.274

Published: 2017

Journal Articles

NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML

Melissa Berrien-Elliott, PhD, Rizwan Romee, MD, Julia Alexandra Wagner, BS, Michelle Becker-Hapak, BS, Carly Neal, Tim Schappe, BS, Matthew McCullen, BS, Megan Cooper, MD PhD, Todd A. Fehniger, MDPhD

Blood (2017) 130 (Supplement 1): 167.

https://doi.org/10.1182/blood.V130.Suppl_1.167.167

Published: 2017

Journal Articles

PTEN Regulates Natural Killer Cell Trafficking in Vivo

Jeffrey W Leong, Stephanie E Schneider, Ryan P Sullivan, PhD, Anvita Singh, Todd A Fehniger, MDPhD

Blood (2014) 124 (21): 753.

https://doi.org/10.1182/blood.V124.21.753.753

Published: 2014

Journal Articles

The IL-15 Superagonist ALT-803 Enhances NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas Directed By an Anti-CD20 Monoclonal Antibody

Maximillian Rosario, MDPhD, Bai Liu, Lin Kong, Stephanie E Schneider, Emily K Jeng, Peter R Rhode, PhD, Hing Wong, PhD, Todd A Fehniger, MDPhD

Blood (2014) 124 (21): 807.

https://doi.org/10.1182/blood.V124.21.807.807

Published: 2014

Journal Articles

Human Cytokine-Induced Memory-like (CIML) NK Cells Are Active Against Myeloid Leukemia in Vitro and in Vivo

Maximillian Rosario, MDPhD, Rizwan Romee, MD, Stephanie E Schneider, Jeffrey W Leong, Ryan P Sullivan, PhD, Todd A Fehniger, MDPhD

Blood (2014) 124 (21): 1117.

https://doi.org/10.1182/blood.V124.21.1117.1117

Published: 2014

NARROW

End of Treatment Peripheral Blood T-Cell Receptor Gene Rearrangement Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma

Ontogeny As a Critical Determinant of Natural Killer Cell Potential and Function

Tocilizumab Is Safe after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations

First-in-Human Clinical Trial of the IL-15 Super-Agonist Complex ALT-803 for Patients Relapsed after Allogeneic Hematopoietic Cell Transplantation

NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML

PTEN Regulates Natural Killer Cell Trafficking in Vivo

The IL-15 Superagonist ALT-803 Enhances NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas Directed By an Anti-CD20 Monoclonal Antibody

Human Cytokine-Induced Memory-like (CIML) NK Cells Are Active Against Myeloid Leukemia in Vitro and in Vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only